These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1667 related items for PubMed ID: 9461044

  • 1. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan 30; 47(RR-2):1-30. PubMed ID: 9461044
    [Abstract] [Full Text] [Related]

  • 2. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM, Centers for Disease Control and Prevention, U.S. Public Health Service Task Force.
    MMWR Recomm Rep; 2002 Nov 22; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [Abstract] [Full Text] [Related]

  • 3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.
    Cochrane Database Syst Rev; 2011 Jul 06; (7):CD003510. PubMed ID: 21735394
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. US Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States, February 25, 2000.
    United States Public Health Service Task Force. Perinatal HIV Guidelines Working Group.
    HIV Clin Trials; 2000 Jul 06; 1(2):39-64. PubMed ID: 11590498
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
    Peters V, Liu KL, Dominguez K, Frederick T, Melville S, Hsu HW, Ortiz I, Rakusan T, Gill B, Thomas P.
    Pediatrics; 2003 May 06; 111(5 Pt 2):1186-91. PubMed ID: 12728136
    [Abstract] [Full Text] [Related]

  • 11. [Recommendations on the use of antiretroviral agents in pregnant women infected with HIV-1].
    Rev Panam Salud Publica; 2001 May 06; 9(5):345-54. PubMed ID: 11476024
    [Abstract] [Full Text] [Related]

  • 12. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, Horo A, Sakarovitch C, Becquet R, Fassinou P, Dequae-Merchadou L, Welffens-Ekra C, Rouzioux C, Leroy V, ANRS 1201/1202 DITRAME PLUS Study Group.
    AIDS; 2005 Feb 18; 19(3):309-18. PubMed ID: 15718842
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA, Whitehouse J, Moye J, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ, Nemo GJ.
    N Engl J Med; 1999 Aug 05; 341(6):385-93. PubMed ID: 10432323
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.
    PLoS Med; 2007 Aug 05; 4(8):e257. PubMed ID: 17713983
    [Abstract] [Full Text] [Related]

  • 17. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.
    Clin Infect Dis; 2008 Feb 15; 46(4):611-21. PubMed ID: 18197758
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida.
    Enferm Infecc Microbiol Clin; 2011 Mar 15; 29(3):209.e1-103. PubMed ID: 21388714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 84.